This Week in Cardiology cover image

Nov 18, 2022, This Week in Cardiology

This Week in Cardiology

00:00

AFib Ablation Versus Drug Trials Are Not Advanceing the Field

At three years, 8.2% in the ablation group versus 25 patients or 16.8% in the drug arm had been hospitalized. That was a relative risk reduction of nearly 70%. Pain rates were low in both arms, but there was a cardiac tamponade in a patient who received ablation. Three patients had transient phrenic nerve injury that resolved in three months, obviously, in the cryoballoon arm.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app